r 56865 has been researched along with singlet oxygen in 1 studies
| Studies (r 56865) | Trials (r 56865) | Recent Studies (post-2010) (r 56865) | Studies (singlet oxygen) | Trials (singlet oxygen) | Recent Studies (post-2010) (singlet oxygen) |
|---|---|---|---|---|---|
| 72 | 1 | 0 | 3,870 | 4 | 2,322 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borgers, M; Ver Donck, L | 1 |
1 other study(ies) available for r 56865 and singlet oxygen
| Article | Year |
|---|---|
Myocardial protection by R 56865: a new principle based on prevention of ion channel pathology.
Topics: Animals; Benzothiazoles; Calcium; Cardiomyopathies; Heart; Lysophosphatidylcholines; Myocardial Contraction; Ouabain; Oxygen; Piperidines; Rabbits; Rats; Singlet Oxygen; Sodium; Sodium Channels; Tetrodotoxin; Thiazoles; Veratridine | 1991 |